A
AGILENT TECHNOLOGIES, INC.NYSEResearch view
Healthcare · Laboratory Analytical Instruments · Large-cap · SEC EDGAR FY 2025-10-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-10-31SectorHealthcare
Market Cap$44.2B
Enterprise Value$45.5B
Income$1.3B
Sales$6.9B
Book/sh$-0.80
Cash/sh$6.35
Dividend TTM$0.99
Payout22%
Employees—
IPO—
Quick Ratio1.52
Current Ratio1.96
Debt/Eq-13.50
EPS (ttm)$4.57
EPS this Y3.2%
EPS past 3/5Y3.0%
Sales past 3/5Y0.5%
EPS Y/Y TTM3.2%
Sales Y/Y TTM6.7%
Shs Outstand281.93M
ROA10.2%
ROE-576.5%
ROIC130.0%
Gross Margin—
Oper. Margin21.3%
Profit Margin18.8%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$6.3B
2021
$6.8B
2022
$6.8B
2023
$6.5B
2024
$6.9B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6.3B | $6.8B | $6.8B | $6.5B | $6.9B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $1.3B | $1.6B | $1.4B | $1.5B | $1.5B |
| Net Income | $1.2B | $1.3B | $1.2B | $1.3B | $1.3B |
| Diluted EPS | $3.94 | $4.18 | $4.19 | $4.43 | $4.57 |
| Operating Cash Flow | $1.5B | $1.3B | $1.8B | $1.8B | $1.6B |
| Free Cash Flow | $1.3B | $1.0B | $1.5B | $1.4B | $1.2B |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $407.0M against $1.6B operating cash
COMMUNITY · $A0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Laboratory Analytical Instruments
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.